Materialise (Nasdaq: MTLS) raised its full-year adjusted EBIT guidance from €10 million-€12 million to €12 million-€14 million, while maintaining its revenue guidance of €273 million-€283 million. The company's second-quarter revenue grew over 8% to €70.1 million, and adjusted EBITDA increased by nearly 16% to €9.6 million. The medical segment was the primary growth driver, with revenue increasing by over 12% and medical device revenue growing by 19%.